For research use only. Not for therapeutic Use.
NAE-IN-M22(Cat No.:I031368) is a potent and selective inhibitor of the NEDD8 activating enzyme (NAE), a key regulator of the NEDDylation pathway. It exerts its inhibitory effects in the micromolar range. NAE-IN-M22 demonstrates significant antiproliferative activity against various cancer cells and induces apoptosis specifically in A549 cells. Moreover, it exhibits the ability to inhibit tumor growth in vivo. These findings suggest that NAE-IN-M22 has the potential as an anticancer agent by targeting the NEDDylation pathway.
Catalog Number | I031368 |
CAS Number | 864420-54-2 |
Synonyms | M22 NEDD8 inhibitor; M22; M-22; M 22; |
Molecular Formula | C20H24Cl2N2 |
Purity | 98% |
Target | Apoptosis |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Store at -20°C |
IUPAC Name | 1-benzyl-N-(2,4-dichlorophenethyl)piperidin-4-amine |
InChI | InChI=1S/C20H24Cl2N2/c21-18-7-6-17(20(22)14-18)8-11-23-19-9-12-24(13-10-19)15-16-4-2-1-3-5-16/h1-7,14,19,23H,8-13,15H2 |
InChIKey | WMEXQHGRMWPOEF-UHFFFAOYSA-N |
SMILES | ClC1=CC=C(C(Cl)=C1)CCNC2CCN(CC3=CC=CC=C3)CC2 |
Reference | 1: Ni S, Chen X, Yu Q, Xu Y, Hu Z, Zhang J, Zhang W, Li B, Yang X, Mao F, Huang J, Sun Y, Li J, Jia L. Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth. Eur J Med Chem. 2020 Jan 1;185:111848. doi: 10.1016/j.ejmech.2019.111848. Epub 2019 Nov 4. PMID: 31732254. |